Opportunity Information: Apply for RFA DK 14 022

  • The National Institutes of Health in the food and nutrition health sector is offering a public funding opportunity titled "Improving Diabetes Management in Young Children with Type 1 Diabetes (DP3)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research.
  • This funding opportunity was created on Jun 19, 2014 and posted on Jun 19, 2014.
  • Applicants must submit their applications by Mar 18, 2015. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $3,500,000.00 to eligible and selected applicants.
  • Eligible applicants include: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Private institutions of higher education Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) County governments Small businesses City or township governments Special district governments Independent school districts For profit organizations other than small businesses Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education.
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Foreign Institutions Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Apply for RFA DK 14 022

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The NIH funding opportunity titled "Improving Diabetes Management in Young Children with Type 1 Diabetes (DP3)" (Funding Opportunity Number RFA-DK-14-022) is designed to push forward practical, innovative research that can make daily type 1 diabetes care safer and more manageable for very young children, specifically those age 5 and under. The focus is not on running a large definitive clinical trial right away, but on building the groundwork for one by supporting projects that create and fine-tune new approaches to diabetes management that realistically fit the lives of young children and their families. Because diabetes in this age group is uniquely challenging, with rapidly changing insulin needs, unpredictable eating and activity patterns, limited ability to recognize or communicate symptoms, and heavy reliance on parents or other caregivers, the FOA centers on strategies that reduce burden while improving safety and outcomes.

The core purpose of the FOA is developmental and preparatory: applicants are expected to develop, refine, and pilot test an intervention. By the end of the award period, NIH expects investigators to have a well-developed and well-characterized strategy that has been shown, in preliminary testing, to be safe, feasible to implement, and acceptable to the intended users (young children and, importantly, their caregivers and care settings). The deliverable is essentially a credible, ready-to-scale intervention package. If the early results look promising, the intervention should be in a position where it can move into a larger, more definitive efficacy trial after this funding ends. In other words, the FOA is aimed at generating the kind of high-quality pilot evidence and implementation know-how that prevents bigger trials from failing due to poor design fit, low usability, or unanticipated safety and adherence problems.

The funding instrument is a grant under a discretionary opportunity category, and the activity is listed under food, nutrition, and health. The relevant CFDA number is 93.847, associated with Diabetes, Digestive, and Kidney Diseases Extramural Research, reflecting the NIH institute mission area tied to diabetes research. The announcement was posted June 19, 2014, with an original and current closing date of March 18, 2015, and an archive date of April 18, 2015, indicating it is no longer open but remains a useful reference point for the kind of development-stage diabetes management research NIH has prioritized. The estimated total funding amount for the opportunity is $3,500,000, and there is no cost sharing or matching requirement, which typically makes it easier for a wider range of organizations to apply without needing to secure additional non-federal funds to meet a match.

Eligibility is broad and includes many types of U.S.-based organizations that could reasonably lead or partner on pediatric diabetes intervention development. Eligible applicants include nonprofits with and without 501(c)(3) status (excluding higher education institutions for that specific nonprofit category), public and private institutions of higher education, state and local governments (including county, city/township, special district governments), independent school districts, and public housing authorities/Indian housing authorities. Small businesses and for-profit organizations (other than small businesses) are also listed as eligible, which signals NIH openness to technology-forward or product-adjacent intervention concepts as long as they align with the public health goal. Tribal entities are explicitly included, both federally recognized tribal governments and other tribal organizations, as well as tribally controlled colleges and universities, reflecting an intent to support work that can reach and fit diverse communities.

The FOA also specifically calls out additional eligible applicants such as Historically Black Colleges and Universities (HBCUs), Hispanic Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Alaska Native and Native Hawaiian Serving Institutions, and faith-based or community-based organizations. Regional organizations and eligible agencies of the federal government are included as well. At the same time, the eligibility language clearly excludes foreign institutions and other non-U.S. entities: non-domestic (non-U.S.) entities are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components (as defined by NIH policy) are not allowed. This means the project leadership, performance sites, and formal components must remain domestic, which can matter for recruitment plans, data coordination, and intervention delivery methods.

In practical terms, a competitive project under this FOA would be expected to do more than propose a good idea. It would need to translate that idea into an intervention that is clearly defined (what it is, who delivers it, how often, in what setting, with what materials and training), grounded in the realities of caring for children under 6, and tested enough to demonstrate that it can be carried out without undue risk and with a strong likelihood of family uptake. "Safe" in this context often implies careful attention to hypoglycemia risk, appropriate monitoring, caregiver decision support, and any technology-related hazards or user errors. "Feasible" generally points to whether families can actually use it consistently, whether clinicians or educators can deliver it in real-world settings, and whether logistics like time, cost, training, and workflow are manageable. "Acceptable" means the intervention is not only clinically sensible but also fits family preferences, cultural context, caregiver stress levels, and the day-to-day unpredictability of preschool-aged children.

Administrative details in the announcement include a reference link to the full FOA text hosted on the NIH grants site (http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-14-022.html). For access issues, NIH directs users to the NIH Office of Extramural Research (OER) webmaster contacts listed in the source data, which is typical for archived opportunities where applicants or researchers may need the official record for compliance, citation, or program planning purposes.

Overall, the opportunity reflects NIH interest in bridging the gap between promising concepts and real-world solutions for families managing type 1 diabetes in the earliest years of life. Rather than funding a final, large-scale efficacy study, it emphasizes intervention development, iterative refinement, and careful pilot testing so that the end product is not just theoretically effective, but usable, safe, and ready to be rigorously evaluated in a subsequent full-scale trial.

FAQs: NIH Grant - Improving Diabetes Management in Young Children with Type 1 Diabetes (DP3) (RFA-DK-14-022)

What is the title and funding opportunity number for this NIH grant?

The funding opportunity is titled "Improving Diabetes Management in Young Children with Type 1 Diabetes (DP3)" and the Funding Opportunity Number is RFA-DK-14-022.

What is the main goal of this funding opportunity?

The main goal is to advance practical, innovative research that makes day-to-day type 1 diabetes care safer and more manageable for very young children. The FOA is designed to support development-stage work that creates, refines, and pilot tests new diabetes management approaches that realistically fit the lives of young children and their families.

Who is the target population for the research supported by this FOA?

The target population is young children with type 1 diabetes age 5 and under, along with the caregivers and care settings that are central to managing diabetes at this age.

Is this grant meant to fund a large definitive clinical trial?

No. The FOA emphasizes developmental and preparatory research rather than launching a large, definitive efficacy trial right away. The intent is to build the groundwork for a later, larger trial by supporting intervention development, refinement, and pilot testing.

What kinds of projects is NIH expecting under this FOA?

NIH expects applicants to develop, refine, and pilot test a diabetes management intervention. Projects should translate an innovative concept into a clearly defined approach that can be implemented in real life for children under 6 and their families.

What should be achieved by the end of the award period?

By the end of the award period, investigators are expected to have a well-developed and well-characterized intervention strategy with preliminary evidence that it is safe, feasible to implement, and acceptable to intended users (young children and caregivers). The end product should be credible and ready to scale into a larger, definitive efficacy trial if early results are promising.

What does it mean that the FOA is "developmental and preparatory"?

It means the focus is on building and de-risking an intervention before a major trial. This includes iterative development and refinement, piloting, and generating practical implementation know-how so that a future large trial is less likely to fail because of poor fit, low usability, safety issues, or adherence problems.

Why is type 1 diabetes management uniquely challenging in children age 5 and under?

The FOA highlights challenges such as rapidly changing insulin needs, unpredictable eating and activity patterns, limited ability of young children to recognize or communicate symptoms, and heavy reliance on parents or other caregivers for all aspects of diabetes management.

What does NIH mean by an intervention being "safe" in this context?

Within the FOA description, "safe" points to careful attention to risks such as hypoglycemia, appropriate monitoring, caregiver decision support, and avoiding technology-related hazards or user errors.

What does NIH mean by an intervention being "feasible"?

"Feasible" generally refers to whether families can use the approach consistently and whether clinicians or educators can deliver it in real-world settings. It also includes whether practical constraints like time, cost, training, and workflow are manageable.

What does NIH mean by an intervention being "acceptable"?

"Acceptable" means the intervention fits family preferences and day-to-day realities, including cultural context, caregiver stress levels, and the unpredictability of preschool-aged children.

What is the expected deliverable or end product of a funded project?

The expected deliverable is a ready-to-scale intervention package: a clearly defined strategy that has been refined and pilot tested, and shown in preliminary work to be safe, feasible, and acceptable for young children and their caregivers.

If a project shows promising early results, what is the intended next step after this funding ends?

If early results are promising, the intervention should be positioned to move into a larger, more definitive efficacy trial after the DP3 award period ends.

What is the estimated total funding amount for this opportunity?

The estimated total funding amount listed for this opportunity is $3,500,000.

Is cost sharing or matching required?

No. The opportunity states there is no cost sharing or matching requirement.

What is the CFDA number associated with this opportunity?

The CFDA number provided is 93.847, associated with Diabetes, Digestive, and Kidney Diseases Extramural Research.

What category and activity area is this opportunity listed under?

The funding instrument is a grant under a discretionary opportunity category, and the activity is listed under food, nutrition, and health.

When was the announcement posted and when did it close?

The announcement was posted on June 19, 2014. The closing date shown is March 18, 2015 (both the original and current closing date). The archive date is April 18, 2015.

Is this funding opportunity currently open?

No. The archive date (April 18, 2015) indicates the opportunity is no longer open, though it remains available as a reference for the type of development-stage research NIH has supported.

Which types of organizations are eligible to apply?

Eligibility is broad and includes U.S.-based nonprofits (with and without 501(c)(3) status, excluding higher education institutions for that specific nonprofit category), public and private institutions of higher education, and various government entities such as state and local governments (including county, city/township, and special district governments). Independent school districts and public housing authorities/Indian housing authorities are also included.

Are for-profit organizations eligible to apply?

Yes. Small businesses and for-profit organizations (other than small businesses) are listed as eligible applicants.

Are tribal entities eligible to apply?

Yes. Federally recognized tribal governments, other tribal organizations, and tribally controlled colleges and universities are explicitly included as eligible applicants.

Are community-based and faith-based organizations eligible?

Yes. The FOA specifically includes faith-based or community-based organizations among eligible applicants.

Are minority-serving institutions included in the eligibility list?

Yes. The FOA explicitly calls out Historically Black Colleges and Universities (HBCUs), Hispanic Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Alaska Native and Native Hawaiian Serving Institutions, and other similar institutions as eligible.

Are federal government agencies eligible to apply?

Yes. Eligible agencies of the federal government are included among eligible applicants.

Are foreign institutions or non-U.S. entities eligible to apply?

No. The eligibility language excludes foreign institutions and other non-U.S. entities. It also states that non-domestic components of U.S. organizations are not eligible and that foreign components (as defined by NIH policy) are not allowed.

What does it mean that non-domestic components and foreign components are not allowed?

It means the project leadership, performance sites, and formal project components must remain domestic (U.S.-based). This can affect recruitment plans, data coordination, and intervention delivery methods.

Where can the full FOA text be found?

The full FOA text is hosted on the NIH grants site at: http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-14-022.html

Who should be contacted for access issues related to the archived FOA?

For access issues, NIH directs users to the NIH Office of Extramural Research (OER) webmaster contacts referenced in the source information.

What kind of intervention details should a competitive application include?

Based on the FOA description, a competitive project would define the intervention clearly: what it is, who delivers it, how often it is delivered, in what setting, and what materials and training are required. It should also be grounded in the realities of caring for children under 6 and include pilot testing to demonstrate safety, feasibility, and acceptability.

Browse more business programs for Diabetes Research

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Food and Nutrition Health

Next opportunity: Critical Path Public Private Partnerships

Previous opportunity: CYCLING HARDWARE TO ANALYZE AND READY GRID SCALE ELECTRICITY STORAGE (CHARGES)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DK 14 022

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DK 14 022) also looked into and applied for these:

Funding Opportunity
Critical Path Public Private Partnerships Apply for RFA FD 14 089

Funding Number: RFA FD 14 089
Agency: Food Drug Administration
Category: Food and Nutrition Health
Funding Amount: $10,500,000
NIDDK Mentored Research Scientist Development Award (K01) Apply for PAR 14 266

Funding Number: PAR 14 266
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Limited Competition Data Coordinating Center for The Environmental Determinants of Diabetes in the Young (TEDDY) Study (UC4) Apply for RFA DK 14 505

Funding Number: RFA DK 14 505
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $20,000,000
NIAID SBIR Technology Transfer Direct Phase II (SBIR TT) (R44) Apply for RFA AI 14 049

Funding Number: RFA AI 14 049
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $1,000,000
NIDDK Cooperative Hematology Specialized Core Centers (U54) Apply for RFA DK 14 001

Funding Number: RFA DK 14 001
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $1,000,000
Limited Competition for the Continuation of the Adult Acute Liver Failure Study Group (U01) Apply for RFA DK 14 504

Funding Number: RFA DK 14 504
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $3,500,000
NIDDK Physician Scientist Diversity Mentoring Award (K05) Apply for RFA DK 14 005

Funding Number: RFA DK 14 005
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
NIDDK Central Repositories Non renewable Sample Access (X01) Apply for PAR 14 301

Funding Number: PAR 14 301
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Type 1 Diabetes TrialNet Clinical Centers (U01) Apply for RFA DK 14 016

Funding Number: RFA DK 14 016
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $450,000
Prevention of Lower Urinary Tract Symptoms in Women Bladder Health Scientific and Data Coordinating Center (PLUS SDCC) (U01) Apply for RFA DK 14 018

Funding Number: RFA DK 14 018
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $750,000
Prevention of Lower Urinary Tract Symptoms in Women Bladder Health Clinical Centers (PLUS CCs) (U01) Apply for RFA DK 14 004

Funding Number: RFA DK 14 004
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $500,000
Limited Competition Data Coordinating Center for Type 1 Diabetes TrialNet (UC4) Apply for RFA DK 14 507

Funding Number: RFA DK 14 507
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $45,000,000
Identification of Novel Targets and Pathways Mediating Weight Loss, Diabetes Resolution and Related Metabolic Disease after Bariatric Surgery in Humans (R01) Apply for RFA DK 14 025

Funding Number: RFA DK 14 025
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $500,000
Limited Competition for the Continuation of the Hepatitis B Research Network Clinical Centers (U01) Apply for RFA DK 14 506

Funding Number: RFA DK 14 506
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Limited Competition for the Continuation of the Hepatitis B Research Network Immunology Center (U01) Apply for RFA DK 14 509

Funding Number: RFA DK 14 509
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Limited Competition for the Continuation of the Hepatitis B Research Network Data Coordination Center (U01) Apply for RFA DK 14 510

Funding Number: RFA DK 14 510
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent
Type 1 Diabetes Complications IMPACT Award (DP3) Apply for RFA DK 14 017

Funding Number: RFA DK 14 017
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $2,000,000
Consortium on Beta cell Death and Survival (HIRN CBDS) (UC4) Apply for RFA DK 14 021

Funding Number: RFA DK 14 021
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $900,000
(Re)Building a Kidney Coordinating Center (U01) Apply for RFA DK 14 009

Funding Number: RFA DK 14 009
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: $1,600,000
(Re)Building a Kidney Cells to Organ (UH2/UH3) Apply for RFA DK 14 010

Funding Number: RFA DK 14 010
Agency: National Institutes of Health
Category: Food and Nutrition Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DK 14 022", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.